Description

BSE announces the listing of 15,099,200 equity shares of Modern Diagnostic & Research Centre Limited with various lock-in periods ranging from February 2026 to January 2029.

Summary

BSE has listed 15,099,200 fully paid equity shares of Modern Diagnostic & Research Centre Limited in dematerialized form. The shares are subject to various lock-in periods, with the earliest lock-in expiring on February 3, 2026, and the latest extending to January 20, 2029.

Key Points

  • Total securities listed: 15,099,200 equity shares
  • All securities are fully paid and in demat form
  • Securities are distributed across 11 distinct ranges with different lock-in periods
  • Lock-in periods range from February 3, 2026 to January 20, 2029
  • Initial lock-in date for most tranches: December 30, 2025

Securities Details

Distribution of Shares by Lock-in Period:

  • 577,600 shares: Lock-in until February 3, 2026 (Distinctive Nos. 11,000,001 to 11,577,600)
  • 584,000 shares: Lock-in until April 4, 2026 (Distinctive Nos. 11,577,601 to 12,161,600)
  • 2,937,600 shares: No lock-in - FREE (Distinctive Nos. 1 to 875,000 and 12,161,601 to 15,099,200)
  • Multiple tranches: Lock-in periods of January 20, 2027, January 20, 2028, and January 20, 2029

Important Dates

  • December 30, 2025: Initial lock-in date for majority of tranches
  • February 3, 2026: Lock-in expiry for 577,600 shares
  • April 4, 2026: Lock-in expiry for 584,000 shares
  • January 20, 2027: Lock-in expiry for multiple tranches (3,370,000 shares total)
  • January 20, 2028: Lock-in expiry for multiple tranches (7,020,000 shares total)
  • January 20, 2029: Lock-in expiry for 2,220,000 shares

Compliance Requirements

  • All listed securities must remain in dematerialized form
  • Lock-in restrictions must be observed as per the specified dates
  • Trading in locked-in securities is restricted until respective lock-in expiry dates

Impact Assessment

This is a standard listing announcement with minimal market impact. The staggered lock-in periods will result in gradual release of shares into the market over approximately 3 years, which helps prevent sudden supply shocks. The availability of 2,937,600 free shares (approximately 19.5% of total) provides immediate liquidity for trading.

Impact Justification

Routine listing announcement for a single company with standard lock-in provisions; limited market-wide impact